Jason Yeh

Statistics

Publications

Citations

533

H-Index

Active since

2002

Affiliations

National Institute on Deafness and Other Communication Disorders(Current)

National Institutes of Health

Jason Yeh is an author at National Institute on Deafness and Other Communication Disorders specializing in oncology, cancer cell signaling, and cancer biology.

Publications per year

2002–2008

Publications

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines

C C Bancroft, Zhong Chen, Jason Yeh et al. · International Journal of Cancer · 2002 · 231 citations · Full text

Medicine, Cancer Biology, Oncology +15

Epigenetic modification of <i>SOCS-1</i> differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas

Jason Yeh, Carter Van Waes, Zhong Chen · Molecular Cancer Therapeutics · 2006 · 114 citations

Life Sciences, Molecular Biology, Oncology +15

A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas

Jason Yeh, Jay Friedman, Bin Yan et al. · International Journal of Cancer · 2008 · 108 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Protein Kinase Casein Kinase 2 Mediates Inhibitor-κB Kinase and Aberrant Nuclear Factor-κB Activation by Serum Factor(s) in Head and Neck Squamous Carcinoma Cells

Ming Yu, Jason Yeh, Carter Van Waes · Cancer Research · 2006 · 80 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–4 of 4